AnPac Bio-Medical Science Co., Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.00
|
|
Average Rating
|
6.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.00
|
-1.55
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-3.60
|
-3.60
|
0.00%
|
|
2022-03-31
|
-0.10
|
-0.13
|
-0.03
|
-30.00%
|
|
2021-09-30
|
-0.13
|
-1.01
|
-0.88
|
-676.92%
|
|
2021-03-31
|
-2.20
|
-0.39
|
1.81
|
82.27%
|
|
2020-09-30
|
-0.18
|
-0.16
|
0.02
|
11.11%
|
|
2020-06-30
|
0.00
|
-0.72
|
-0.72
|
0.00%
|
|
2020-03-31
|
0.00
|
-0.36
|
-0.36
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.92
|
|
2019-12-31
|
-1.29
|
|
2018-12-31
|
-0.47
|